Prime Medicine, Inc. (PRME)
2.98
-0.01
(-0.33%)
USD |
NASDAQ |
Oct 02, 16:00
3.00
+0.02
(+0.67%)
After-Hours: 20:00
Prime Medicine Gross Profit Margin (Quarterly) : -54.68% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -54.68% |
| March 31, 2026 | -116.8% |
| December 31, 2025 | -123.9% |
| September 30, 2025 | -53.55% |
| June 30, 2025 | -67.17% |
| Date | Value |
|---|---|
| March 31, 2025 | -16.92% |
| December 31, 2024 | 21.35% |
| September 30, 2024 | -645.5% |
| June 30, 2024 | |
| March 31, 2024 | -122.5% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -1.00K% |
| Twist Bioscience Corp. | 52.76% |
| Intellia Therapeutics, Inc. | 72.58% |
| Q32 Bio, Inc. | -- |
| Revolution Medicines, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -204.2% |
| Return on Assets | -51.49% |
| Return on Invested Capital | -90.22% |
| Profit Margin (Quarterly) | -3.65K% |
| Operating Margin (Quarterly) | -3.75K% |
| Return on Net Operating Assets | -130.1% |